Thus, the cutoff of hs-cTnI in stratifying cardiac damage in non-severe patients with COVID-19 was recommended to be redefined, and the cutoff threshold of abnormality for hs-cTnI was suggested to be lower than the 99th percentile. Here, TNNI3 is linked to COVID-19.